HomeHome
ProductsProducts
Bioactive CompoundsBioactive Compounds
Target & Pathway ModulatorsTarget & Pathway Modulators
MPOMPO
VerdiperstatVerdiperstat

Verdiperstat

CAS No.	890655-80-8
MDL No.	N/A
MF	C₁₁H₁₅N₃O₂S
MW	253.32
InChI Key	FVJCUZCRPIMVLB-UHFFFAOYSA-N

CUSTOM SYNTHESIS

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	890655-80-8
Product Name	Verdiperstat

Irritant

Signal Word:Warning

HCode:H302

PCode:P264-P270-P301+P317-P330-P501

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020

PMID: 32020584 PMC: PMC7160657 DOI: 10.1111/imm.13175

Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.

Neurotoxicity research • Vol. 28, Issue 3 • 2015

PMID: 26194617 PMC: PMC4556742 DOI: 10.1007/s12640-015-9547-7

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Brain : a journal of neurology • Vol. 138, Issue Pt 9 • 2015

PMID: 26137956 DOI: 10.1093/brain/awv184

Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.

Nuclear medicine and biology • Vol. 42, Issue 6 • 2015

PMID: 25726760 DOI: 10.1016/j.nucmedbio.2015.02.001

Products
- CDMO Compounds
- API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact

HomeHome
ProductsProducts
Bioactive CompoundsBioactive Compounds
Target & Pathway ModulatorsTarget & Pathway Modulators
MPOMPO
VerdiperstatVerdiperstat

Verdiperstat

CAS No.	890655-80-8
MDL No.	N/A
MF	C₁₁H₁₅N₃O₂S
MW	253.32
InChI Key	FVJCUZCRPIMVLB-UHFFFAOYSA-N

CUSTOM SYNTHESIS

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	890655-80-8
Product Name	Verdiperstat

Irritant

Signal Word:Warning

HCode:H302

PCode:P264-P270-P301+P317-P330-P501

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020

PMID: 32020584 PMC: PMC7160657 DOI: 10.1111/imm.13175

Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.

Neurotoxicity research • Vol. 28, Issue 3 • 2015

PMID: 26194617 PMC: PMC4556742 DOI: 10.1007/s12640-015-9547-7

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Brain : a journal of neurology • Vol. 138, Issue Pt 9 • 2015

PMID: 26137956 DOI: 10.1093/brain/awv184

Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.

Nuclear medicine and biology • Vol. 42, Issue 6 • 2015

PMID: 25726760 DOI: 10.1016/j.nucmedbio.2015.02.001

Your Partner for
Complex Chemistry

About Us
Perspectives
Products
Contact

Preclinical Development
Technologies
Custom Synthesis

Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT

Westerstraat 10, 3016 DH, Rotterdam, The Netherlands

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|

Verdiperstat

Pricing & Availability

Product Information

Safety Information

Properties

Verdiperstat

Pricing & Availability

Product Information

Safety Information

Properties

Documentation

Verdiperstat

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.

Verdiperstat

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.

Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.

Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing.

Documentation